MedPath

To see the role of oral zinc supplementation in reduction of mortality in neonatal sepsis

Phase 1
Conditions
Health Condition 1: P369- Bacterial sepsis of newborn, unspecifiedHealth Condition 2: P369- Bacterial sepsis of newborn, unspecified
Registration Number
CTRI/2022/07/044228
Lead Sponsor
Pediatric Department Research Fund
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Neonates more than or equal to 32 weeks gestation

2. Age < 28 days

3. On significant enteral feeds (more than 50%)

4. Infants considered to be septic includes any of the following ;

i) Infant having predisposing factors like prom, foul smelling liquor or more than 3 pv examination during 24 hours

ii) Rds with radiological signs of pneumonia

5.Atleast 2 of the screening tests positive for sepsis (Procalcitonin, CRP, ANC, TLC, Micro ESR, immature/total neutrophil)

Exclusion Criteria

Neonates with:

1. Major congenital malformation

2. Necrotizing enterocolitis

3. Who have undergone surgery

4. With Apgar score < 6 at 5 mins

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath